Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Expansion of CD26 positive fibroblast population promotes keloid progression

Journal Article · · Experimental Cell Research
 [1];  [2];  [1];  [3]; ; ; ; ;  [1];  [1];  [1]
  1. Department of Plastic and Reconstructive Surgery, Shanghai 9th People's Hospital (China)
  2. Shanghai Tissue Engineering Key Laboratory, Shanghai Jiao Tong University School of Medicine, Shanghai 200011 (China)
  3. Clinic for Plastic, Hand and Burns Surgery, RWTH Aachen University Hospital, 52074 Aachen (Germany)
Background: Keloid is a skin fibrosis disease that characterised by invasive growth of fibroblasts and aberrant deposition of extracellular matrix. Studies indicated that keloid fibroblasts (KFs) is a class of ‘activated’ fibroblasts, which show accelerated proliferation and excessive extracellular matrix formation as compared with normal fibroblasts (NFs). However, the mechanism underlying keloid fibroblasts dysfunction is still unknown. Objective: To verify CD26 expression difference between KFs and NFs, and investigate the function of CD26 positive fibroblasts in keloid progression. Methods: KFs and NFs were isolated from Keloid tissues and normal skin tissues respectively. Flow cytometry was performed to isolate CD26+/CD26- fibroblasts from KFs and NFs. Proliferation of different fibroblasts were analyzed by CCK8 assay and Ki 67 straining. Profibrotic phenotype difference was detected by qRT-PCR, western blot, ELISA and immunofluorescence. Scratching experiment and transwell assay were used to assess invasion ability of CD26+/CD26- fibroblasts. Diprotin A was used as a CD26 inhibitor to further investigated the function of CD26 fibroblasts in keloid disease. Result: CD26 expression was increased in KFs, and the proportion of CD26+ fibroblasts was significantly increased in KFs. Cell viability analysis showed that CD26+ fibroblasts was more active in proliferation. Furthermore, the expression of profibrotic genes were increased in CD26+ fibroblasts, including TGF-β1, IGF-1, IL6, collagen 1, collagen 3 and fibronectin. And meanwhile, CD26+ fibroblasts showed stronger invasion ability as compared to CD26- fibroblasts. Moreover, Diprotin A significantly suppressed proliferation and extracellular matrix secretion of CD26+ fibroblasts isolated from keloid tissues. Conclusion: Our findings suggest that CD26+ fibroblasts possess proliferation advantage in compare to CD26- fibroblasts, and the advantage caused expansion of CD26 positive fibroblast population promotes keloid progression.
OSTI ID:
22738135
Journal Information:
Experimental Cell Research, Journal Name: Experimental Cell Research Journal Issue: 1 Vol. 356; ISSN 0014-4827; ISSN ECREAL
Country of Publication:
United States
Language:
English

Similar Records

Kindlin-2 promoted the progression of keloids through the Smad pathway and Fas/FasL pathway
Journal Article · Sun Nov 14 23:00:00 EST 2021 · Experimental Cell Research · OSTI ID:23195469

CTRP6 inhibits fibrogenesis in TGF-β1-stimulated human dermal fibroblasts
Journal Article · Fri Jul 08 00:00:00 EDT 2016 · Biochemical and Biophysical Research Communications · OSTI ID:22598780

miR-141-3p inhibits fibroblast proliferation and migration by targeting GAB1 in keloids
Journal Article · Sat Aug 19 00:00:00 EDT 2017 · Biochemical and Biophysical Research Communications · OSTI ID:22719033